Recently released draft guidance from the FDA on direct-to-consumer TV ads has triggered a wide range of reactions, according to John Kamp, Executive Director of the Coalition for Healthcare Communication. In a recent column posted Monday on the CHC website, Kamp states that the “analysis and commentary on the FDA guidance ranges from ‘not much new here’ to near hysteria.” Kamp addresses several sticking points in the guidance raised by industry and encourages readers to submit their comments to the agency. Read more.

Full Story:

Related Summaries